lepirudin (Celgene Europe)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug Namelepirudin (Celgene Europe)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1997/03/13
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesCelgene Europe LtdNational Cancer Institute
Active IndicationsN/A
Inactive Indications